Studies in BL, CLL, and MCL have also confirmed FoxO1's role in promoting clonal expansion and cell survival, with both AS1842856 and cpd10 proving effective in vitro and in vivo [9, 10, 106, 108]. Here, FOXO1 is linked to B-cell chronic lymphocytic leukemia.